1 Immunohistochemical analyses and live cortical imaging o
2 cterized in flow cytometric, histologic, and
immunohistochemical analyses as well as RNA analyses.
3 te element modeling, mechanical testing, and
immunohistochemical analyses at multiple time points thr
4 Immunohistochemical analyses confirmed selective ChR2 ex
5 Biochemical and
immunohistochemical analyses confirmed the TSPO small-an
6 Virological, histopathological, and
immunohistochemical analyses confirmed uncontrolled BDBV
7 We performed
immunohistochemical analyses for expression of Notch and
8 Immunohistochemical analyses of 9 biopsied pigmented les
9 We performed
immunohistochemical analyses of a 445 PDAC specimens, co
10 Immunohistochemical analyses of CRC tissues further corr
11 We performed
immunohistochemical analyses of distal ileum tissues fro
12 Immunohistochemical analyses of hagfish tissues and bloo
13 Western blot and
immunohistochemical analyses of heart tissue samples fur
14 We performed
immunohistochemical analyses of human tissue microarrays
15 We performed
immunohistochemical analyses of inflamed and noninflamed
16 repertoire is derived from histological and
immunohistochemical analyses of insulitis, the identific
17 Immunohistochemical analyses of kidney biopsies from liv
18 ed vascular network with pharmacological and
immunohistochemical analyses of pericytes, the capillary
19 Further, echocardiographic and
immunohistochemical analyses of recipient hearts showed
20 quence, whole-exome and genome sequence, and
immunohistochemical analyses of select samples.
21 Immunohistochemical analyses of the oral lesions reveale
22 We performed
immunohistochemical analyses on tissue microarrays of 10
23 Immunohistochemical analyses reveal that endogenous GLP-
24 Pharmacological and
immunohistochemical analyses reveal that these neurons l
25 Lineage tracing and
immunohistochemical analyses revealed clonal expansion o
26 Immunohistochemical analyses revealed that the mPOA modu
27 Immunohistochemical analyses showed that cells produced
28 Our in silico and
immunohistochemical analyses showed that KIAA1199 is spe
29 autoantibody detection, and detailed tissue
immunohistochemical analyses were performed.
30 Immunohistochemical analyses with TSPO antisera, methoxy
31 atory molecules, determined by pathology and
immunohistochemical analyses, in a training set of 228 H
32 In
immunohistochemical analyses, we found that the invasive
33 inal tissues were collected from embryos for
immunohistochemical analyses.
34 med gene expression, immunofluorescence, and
immunohistochemical analyses.
35 were collected and analyzed by histology and
immunohistochemical analyses.
36 ngle nucleotide polymorphisms, and performed
immunohistochemical analyses.
37 PCR, enzyme-linked immunosorbent assay, and
immunohistochemical analyses.
38 t generation sequencing, protein expression (
immunohistochemical analysis [IHC]), and gene amplificat
39 Immunohistochemical analysis also showed that p27 was mi
40 Immunohistochemical analysis also suggested that CDCP1 i
41 Immunohistochemical analysis and immunofluorescent micro
42 Immunohistochemical analysis and immunofluorescent micro
43 Immunohistochemical analysis confirmed enhanced expressi
44 Immunohistochemical analysis confirmed localization of A
45 Second, western blot and
immunohistochemical analysis confirmed that Sal-1 suppre
46 Immunohistochemical analysis demonstrated colocalization
47 Immunohistochemical analysis demonstrated that the inhib
48 Immunohistochemical analysis demonstrated that YC-1 + GI
49 Tumors were subjected to
immunohistochemical analysis for immune checkpoints (PD-
50 Muscle biopsy and
immunohistochemical analysis found deficiencies of lamin
51 grammed cell death 1 ligand 1) expression by
immunohistochemical analysis has been used as a predicti
52 grammed cell death 1 ligand 1) expression by
immunohistochemical analysis has been used as a predicti
53 Immunohistochemical analysis identified a selective redu
54 Immunohistochemical analysis indicated that DOX-HK-MPEG-
55 andardization, and prediction of response by
immunohistochemical analysis is additionally limited by
56 We conducted
immunohistochemical analysis of 2,394 patient specimens
57 Immunohistochemical analysis of a collection of human br
58 Immunohistochemical analysis of AMPAR subunits in mature
59 Immunohistochemical analysis of chronic pancreatitis (CP
60 Consistently,
immunohistochemical analysis of clinical breast tumor ti
61 Immunohistochemical analysis of FLNC localization in car
62 u]-LLP2A uptake than uninfected tissues, and
immunohistochemical analysis of granulomas with known [(
63 n, and dosimetry studies in mice, as well as
immunohistochemical analysis of harvested tumors, were p
64 h phage display-based functional proteomics,
immunohistochemical analysis of human pancreatic ductal
65 This result was subsequently confirmed by
immunohistochemical analysis of MCAM and LAMA4 expressio
66 Immunohistochemical analysis of mouse cerebellar tissue
67 Immunohistochemical analysis of paired tumor biopsies re
68 n significantly reduced tumor growth in vivo
Immunohistochemical analysis of primary human melanomas
69 Immunohistochemical analysis of spleen sections from wil
70 e wound area was subjected to histologic and
immunohistochemical analysis of the epithelial gap, numb
71 However,
immunohistochemical analysis of the kidneys of mice trea
72 bin, leukocytes, platelets, creatinine), and
immunohistochemical analysis of the kidneys.
73 Immunohistochemical analysis of the MAP2K1 downstream ta
74 Immunohistochemical analysis of the tumorous lungs showe
75 Immunohistochemical analysis of untreated tumors confirm
76 Immunohistochemical analysis revealed a reduction in apo
77 Immunohistochemical analysis revealed a significant redu
78 Immunohistochemical analysis revealed extensive expressi
79 Immunohistochemical analysis revealed smaller beta-cell
80 Finally,
immunohistochemical analysis revealed strong expression
81 AP in the liver and cisplatin in the kidney,
immunohistochemical analysis revealed the elevated expre
82 Immunohistochemical analysis revealed upregulated tubula
83 In the present study,
immunohistochemical analysis reveals a spatiotemporal ex
84 Immunohistochemical analysis reveals a strong positive c
85 R2-enriched subtype, ESR1, treatment arm, ER
immunohistochemical analysis scores, Genomic Grade Index
86 In accordance with these data,
immunohistochemical analysis showed that both leukotrien
87 Immunohistochemical analysis showed that Hic-5 is primar
88 Immunohistochemical analysis showed that IL-17C expressi
89 Immunohistochemical analysis showed that TRAF1 expressio
90 Immunohistochemical analysis substantiated that Galectin
91 Here we use detailed
immunohistochemical analysis to document the expression
92 sis is possible with cytopathologic exam and
immunohistochemical analysis using ultrasound-guided FNA
93 ematoxylin-eosin (H&E)-stained sections, and
immunohistochemical analysis was performed to assess CD8
94 Immunohistochemical analysis was positive for estrogen a
95 lysis for BRAF splicing, RNA sequencing, and
immunohistochemical analysis were performed on tumor sam
96 By means of
immunohistochemical analysis, all GIST cells expressed C
97 and placental maternal mononuclear cells by
immunohistochemical analysis, and no antigen was seen in
98 Outcomes were HPV status as measured by p16
immunohistochemical analysis, HPV16 DNA in situ hybridiz
99 Outcomes were HPV status as measured by p16
immunohistochemical analysis, HPV16 DNA in situ hybridiz
100 We performed
immunohistochemical analysis, knockdown and overexpressi
101 iagnostic assays, including molecular tests,
immunohistochemical analysis, pathologic analysis, and e
102 Here, through neuroanatomical and
immunohistochemical analysis, we identified, in the crab
103 ival tissues was also assessed using in situ
immunohistochemical analysis.
104 Expression of TrkA was explored by
immunohistochemical analysis.
105 ts, flow cytometry, histologic analysis, and
immunohistochemical analysis.
106 Thirty-seven samples underwent
immunohistochemical analysis.
107 nstrated by ELISA for TIE-2 in lysates or by
immunohistochemical analysis.
108 t cytopathological examination that included
immunohistochemical analysis.
109 ity, rapid solidification, and its impact on
immunohistochemical analysis.
110 Immunohistochemical and autoradiographic findings confir
111 Immunohistochemical and gene expression analyses were al
112 inflammation and senescence were assessed by
immunohistochemical and immunofluorescence staining of h
113 In this study, dual
immunohistochemical and immunofluorescence techniques we
114 We performed
immunohistochemical and immunofluorescent analyses of 11
115 We performed a series of postmortem
immunohistochemical and immunofluorescent stainings, as
116 Significant strides in the
immunohistochemical and molecular signature of AITL have
117 Immunohistochemical and mutational analyses of the patie
118 Immunohistochemical and quantitative polymerase chain re
119 We used
immunohistochemical and quantitative polymerase chain re
120 Here we use genetic,
immunohistochemical and transcriptional immunoprofiling,
121 hese malignant vascular sarcomas demonstrate
immunohistochemical and ultrastructural features typical
122 We used behavioral, electrophysiological,
immunohistochemical,
and chemogenetic strategies to targ
123 d Measures: The clinical, histopathological,
immunohistochemical,
and follow-up features of 33 patien
124 tual fear conditioning by using biochemical,
immunohistochemical,
and gene expression analyses.
125 Histopathologic,
immunohistochemical,
and genetic study results of tumor
126 assessed 206 patients from a morphological,
immunohistochemical,
and immunogenetic perspective.
127 whole-mounts were evaluated by quantitative,
immunohistochemical,
and intracellular labeling approach
128 case series study of the clinicopathologic,
immunohistochemical,
and molecular features of 33 patien
129 ollected and analyzed by immunofluorescence,
immunohistochemical,
and quantitative real-time polymera
130 We describe the histopathologic,
immunohistochemical,
and ultrastructural findings from t
131 Immunohistochemical (
anti-human vWF, CD45, GFAP, and Iba
132 ns in the gastrointestinal tract, we used an
immunohistochemical approach in normal adult rat small i
133 In this study, we combined an
immunohistochemical approach, laser microdissection, and
134 Using genetic, genomic, and
immunohistochemical approaches, we show that this group
135 unique type of complementary information to
immunohistochemical assays of receptor kinase population
136 e assessed by histopathological examination,
immunohistochemical assays using a mouse anti-Zika virus
137 Analysis of
immunohistochemical assays using antibodies targeting th
138 uted to 3 sites that performed the following
immunohistochemical assays: 28-8 antibody on the Dako Li
139 (T1/2) was compared with a semiquantitative
immunohistochemical assessment (grade 0-3) of MRP1 and P
140 ther investigated promising novel markers by
immunohistochemical assessment of IPF lung tissue.
141 Immunohistochemical assessment of LAT1/LAT2/CD98 amino a
142 we could show that the
immunohistochemical assessment of MYC and the histomorph
143 Immunohistochemical assessments of these proteins in can
144 Histological,
immunohistochemical,
biochemical, functional, and behavi
145 al signs of hyperalgesia are correlated with
immunohistochemical changes of peptidergic and non-pepti
146 subcutaneous lesion showed histological and
immunohistochemical characteristics of RDD.
147 t lesions with correlation to histologic and
immunohistochemical characteristics.
148 Immunohistochemical characterization of infiltrating MCs
149 Immunohistochemical characterization reveals that the FT
150 e at C-fiber inputs, a view supported by our
immunohistochemical colabeling data.
151 Histologic and
immunohistochemical comparison with the human SP at corr
152 mical analysis of plasma cytokine levels and
immunohistochemical confirmation of microglial activity
153 Finally,
immunohistochemical data indicate that LDTg amylin recep
154 We present
immunohistochemical data of structural proteins (NF200,
155 Immunohistochemical data show that a systemically admini
156 Immunohistochemical data show that GLP-1-producing neuro
157 The findings can be explained by
immunohistochemical data showing increased expression of
158 Our
immunohistochemical data, combined with flow cytometry (
159 Immunohistochemical detection of pimonidazole adducts on
160 The
immunohistochemical distribution of sbLPXRFa cells and f
161 Immunohistochemical double labeling studies with YFP and
162 clinicopathologic data of ERG and IL-6 using
immunohistochemical double staining and correlated the r
163 Using a combination of
immunohistochemical,
electrophysiological, and Ca(2+) im
164 Immunohistochemical evaluation revealed microglial and a
165 For autoradiography and
immunohistochemical evaluation, additional rats were dec
166 Immunohistochemical evidence for HDM-induced DNA DSBs wa
167 79, respectively) and did not correlate with
immunohistochemical evidence of apoptosis.
168 The results of this study provide
immunohistochemical evidence that the posterior hyaloid
169 In tandem with
immunohistochemical evidence, we find that some tumors m
170 tors, has been limited by a lack of reliable
immunohistochemical evidence.
171 t of cerebral vasospasm, permits outstanding
immunohistochemical examination of non-vasospasm compone
172 on analysis, next-generation sequencing, and
immunohistochemical examination, down-regulation of Notc
173 Further, morphological and
immunohistochemical examinations and quantifications ind
174 f MET to chromosome 7, 4.3) and strong c-Met
immunohistochemical expression (mean H score, 253) than
175 PD-L1
immunohistochemical expression is thought to represent a
176 (18)F-FDHT and (18)F-FES uptake on PET with
immunohistochemical expression of AR and ER in biopsies
177 haled technetium 99m ((99m)Tc)-sestamibi and
immunohistochemical expression of bronchopulmonary multi
178 The
immunohistochemical expression of Ki67 and TUNEL in AG/I
179 Overlapping retention of GFP and
immunohistochemical expression of Krt15, DeltaNp63, Sox9
180 The morphologic and
immunohistochemical features of SPCRP support the invasi
181 itro syncytialization was congruent with the
immunohistochemical findings in preeclamptic placenta as
182 with clinical, radiologic, morphologic, and
immunohistochemical findings is particularly important i
183 orrelation between RCM, histopathologic, and
immunohistochemical findings.
184 in the submucosa were quantified by means of
immunohistochemical identification and computerized imag
185 Structural and
immunohistochemical (
IHC) analyses showed preferential d
186 Local ER
immunohistochemical (
IHC) analyses, HER2 fluorescence in
187 162 patients with both HPV serology and p16
immunohistochemical (
IHC) measures available, both measu
188 Results According to their
immunohistochemical (
IHC) profile, tumors were classifie
189 Immunohistochemical (
IHC) results showed significantly r
190 gistration of the GSK1265744 ion images with
immunohistochemical images established that the drug was
191 es were collected and analyzed by histology,
immunohistochemical,
immunoblot, enzyme-linked immunosor
192 Immunohistochemical,
immunocytochemical, and immunoblot
193 uated by routine light microscopy, including
immunohistochemical/
immunofluorescent staining for CD31,
194 This was addressed by
immunohistochemical/
immunofluorescent stainings performe
195 Intestines and organoids were analyzed by
immunohistochemical,
in situ hybridization, RNA sequence
196 Upon
immunohistochemical inspection of RA, osteoarthritis (OA
197 ; mean [SD] age, 75.0 [7.8] years) underwent
immunohistochemical investigation.
198 d bone, but the fluorescence of proteins and
immunohistochemical labels was maintained over weeks.
199 human breast cancer specimens, we found that
immunohistochemical levels of SEMA3A correlated with the
200 Immunohistochemical localization study showed that BxPrx
201 As pimonidazole is a widely used
immunohistochemical marker of tissue hypoxia, it is like
202 l lesions stained with hematoxylin-eosin and
immunohistochemical markers (melan-A, microphthalmia-ass
203 Immunohistochemical markers (n = 727 women) and Agilent
204 0 years) were investigated with histological/
immunohistochemical markers for cortical laminar archite
205 ents we assessed the additional value of the
immunohistochemical markers MYC, MINA53, and Ki67 in pre
206 ry glands were analyzed for tumor number and
immunohistochemical markers of proliferation and differe
207 rafish, we studied circadian distribution of
immunohistochemical markers of the cell division cycle (
208 Examples include the introduction of novel
immunohistochemical markers that serve as surrogates for
209 We used
immunohistochemical methods to characterize the cellular
210 zation and diversity across species, we used
immunohistochemical methods to examine ipRGCs in tree sh
211 Transgenic,
immunohistochemical,
molecular-genetic, and fluorescence
212 es, we generated high-resolution large-scale
immunohistochemical mosaic images of mouse brain that pr
213 present study provides the first systematic
immunohistochemical neuroanatomical investigation of the
214 r caudate nucleus, followed by sacrifice and
immunohistochemical or western blot analyses.
215 s to conduct a comprehensive overview of the
immunohistochemical phenotype of the infiltrate in histi
216 gative in the primary BrCa cohort and became
immunohistochemical positive (3+) in the paired BrM with
217 Immunohistochemical positivity for p4E-BP1 or insulin-li
218 Extensive gene and
immunohistochemical profiling confirmed that the derived
219 Tumor size and
immunohistochemical quantification at day 0 and at sacri
220 Liver tissues were collected and analyzed by
immunohistochemical quantitative polymerase chain reacti
221 rrier integrity were assessed by histologic,
immunohistochemical,
quantitative reverse transcription
222 ions between PET uptake and semiquantitative
immunohistochemical scoring (percentage positive cells x
223 Immunohistochemical screening of 201 patients (2011-2013
224 Immunohistochemical staining against podoplanin and intr
225 MP-2 knock-out mice for NFATc1 expression by
immunohistochemical staining and found significant reduc
226 -PSMA PET/CT findings and PSMA expression in
immunohistochemical staining and generate a cutoff value
227 Consistently,
immunohistochemical staining and in vitro binding assays
228 Immunohistochemical staining and Western blot analyses s
229 was validated in more than 300 tumors using
immunohistochemical staining and western blot.
230 Immunohistochemical staining demonstrated that Ebf3 and
231 Immunohistochemical staining detected Cry2 in the hemisp
232 Immunohistochemical staining for ICAM-1, P-selectin, nit
233 hatic vessel density (LVD) was determined by
immunohistochemical staining for podoplanin.
234 Immunohistochemical staining for RUNX1 showed reactivity
235 ity of di- and tetranucleotides (EMAST), and
immunohistochemical staining illustrated a complete loss
236 analyses of the SUVmax of PCA, validated by
immunohistochemical staining in 62 tissue samples, showe
237 Immunohistochemical staining in an aromatase reporter mo
238 Serum tryptase levels and tryptase
immunohistochemical staining in skin biopsies were also
239 in TILs, defined as greater than 5% positive
immunohistochemical staining in the respective cell popu
240 The PD-L1
immunohistochemical staining intensity of 78 treated BCC
241 BAP1 expression was evaluated by
immunohistochemical staining of formalin-fixed, paraffin
242 Immunohistochemical staining of healthy tissues revealed
243 By
immunohistochemical staining of hepatic tumor tissue fro
244 We performed an
immunohistochemical staining of Ki67 and TUNEL and quant
245 Immunohistochemical staining of mice and human brain sli
246 Immunohistochemical staining of patient samples revealed
247 Finally, by
immunohistochemical staining of primary breast tissue mi
248 Our data support the role of BAP1
immunohistochemical staining of primary uveal melanoma t
249 the direct regulation of Tbx5 on Pcsk6 using
immunohistochemical staining of pSHF, ChIP-quantitative
250 Immunohistochemical staining of the hippocampus detected
251 Furthermore,
immunohistochemical staining of the NFPAs clinical sampl
252 In patients,
immunohistochemical staining of tissue microarrays and m
253 VDR and RXR expression were assessed by
immunohistochemical staining of tumor microarrays (n = 6
254 Immunohistochemical staining on formalin-fixed BCCs from
255 gic pRCC subtype in combination with the MYC
immunohistochemical staining patterns allows a more accu
256 Immunohistochemical staining revealed stronger tumor cel
257 Immunohistochemical staining showed increased expression
258 Immunohistochemical staining showed that RNF41 expressio
259 In the present study, we have found by
immunohistochemical staining that both LXRalpha and LXRb
260 and mass spectrometry, was confirmed by dual
immunohistochemical staining using commercial antibodies
261 ts of animals characterized at G90 and G135,
immunohistochemical staining was performed, and 3D struc
262 Immunohistochemical staining was used to identify active
263 Immunohistochemical staining was used to localize VEGFR2
264 To confirm the presence of macrophages, CD68
immunohistochemical staining was used.
265 Immunohistochemical staining with an antibody specific f
266 Autoradiography,
immunohistochemical staining, and HGF ELISA assays confi
267 vations, however, predated radioimmunoassay,
immunohistochemical staining, and other molecular studie
268 and survival, which was further validated by
immunohistochemical staining.
269 d for somatostatin receptor subtype-2 (sst2)
immunohistochemical staining.
270 are based on interpretation of, for example,
immunohistochemical staining.
271 fied by RNA array profiling and confirmed by
immunohistochemical staining.
272 g quantitative polymerase chain reaction and
immunohistochemical staining.
273 Immunohistochemical stainings for calprotectin in renal
274 Routine histopathology and
immunohistochemical stainings for CD3, CD4, CD8, CD25, F
275 ho-tau Ser202 and Thr205) and CP13 (pSer202)
immunohistochemical stainings] pathological inclusions,
276 ndard hematoxylin-eosin-stained sections and
immunohistochemical stains for MART-1, HMB-45, microphth
277 Immunohistochemical studies for biomarkers were performe
278 In this work,
immunohistochemical studies identified extravascular fib
279 rodent brain, underlining the importance of
immunohistochemical studies in humans.
280 are not enough for a definite diagnosis and
immunohistochemical studies may be required.
281 Gene expression analysis,
immunohistochemical studies of MM patient bone marrow, r
282 ata, hematoxylin-eosin-stained sections, and
immunohistochemical studies of smooth muscle actin (SMA)
283 Immunohistochemical studies previously obtained on the c
284 Immunohistochemical studies revealed that Sox9 and Col2
285 Immunohistochemical studies showed that the tumor was po
286 Immunohistochemical studies showed that tissue damage du
287 were used for lesion surface evaluation and
immunohistochemical studies, and whole descending aorta
288 protein (GFAP) expressions were detected by
immunohistochemical studies.
289 patients were processed for histological and
immunohistochemical studies.
290 s and provides guidelines on performing such
immunohistochemical studies.
291 udy was to develop a practical and objective
immunohistochemical technique to quantify IDO-1 expressi
292 We used pharmacological, molecular, and
immunohistochemical techniques to assess the role of CRF
293 In this study, we used
immunohistochemical techniques to firstly, visualize and
294 Biochemical analyses and
immunohistochemical techniques were used to determine el
295 on in detail using in situ hybridization and
immunohistochemical techniques, and report two unique ch
296 mined in wildtype and Ano1(/+egfp) mice with
immunohistochemical techniques.
297 tically relevant cytogenetic, molecular, and
immunohistochemical testing methods.
298 r viral status, as assessed by serologic and
immunohistochemical testing.
299 roscopy-based approach with semiquantitative
immunohistochemical validation.
300 ig (Sus scrofa domesticus) were evaluated by
immunohistochemical visualization of choline acetyltrans